COMMUNIQUÉS West-GlobeNewswire

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
07/06/2018
COPENHAGEN, Denmark, June 7, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company's share capital has been increased by nominally DKK 655,000 as a consequence of employees' exercise of [...]
Genetic Technologies Announces Binding Project Shivom Agreement
07/06/2018
MELBOURNE, Australia, June 07, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE), “ Company ”, “ GTG ”), a diversified molecular diagnostics company embracing blockchain technologies across [...]
Hope Pharmaceuticals Files Supplemental New Drug Application to the Food and Drug Administration for Sodium Thiosulfate Injection
07/06/2018
SCOTTSDALE, Ariz., June 07, 2018 (GLOBE NEWSWIRE) -- Hope Pharmaceuticals today announced that the company filed a Supplemental New Drug Application to the United States Food and Drug Administration (FDA) for the use of [...]
Amarin Sponsors Three Scientific Presentations Scheduled for American Diabetes Association Scientific Sessions
07/06/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, June 07, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Enzymatica AB: Enzymatica secures funding for operations
07/06/2018
Press release June 7, 2018 Enzymatica secures funding for operations Enzymatica has received a bridge loan of total SEK 30 million from three of its principle owners to fund the business for 2018. At the same time, the [...]
LIDDS: Major European Investment Funds invest 21,7 MSEK in a direct share issue
07/06/2018
LIDDS AB (publ) has decided on a direct share issue to Nyenburgh Holding BV, AESCAP 2.0 and BWG Invest, all being international funds that invests in closely selected European biotech- and pharma companies. The raised [...]
VALNEVA Announces the Availability of Documentation for its Meeting of Shareholders
07/06/2018
Valneva Announces the Availability of Documentation for its Meeting of Shareholders Lyon (France), June 7, 2018 - The Shareholders of Valneva SE ("Valneva" or "the Company") are invited to participate in the Company's [...]
VALNEVA annonce la mise à disposition des documents préparatoires à l'Assemblée d'actionnaires
07/06/2018
Valneva annonce la mise à disposition des documents préparatoires à l'Assemblée d'actionnaires Lyon (France), 7 juin 2018 - Les actionnaires de la société Valneva SE (ci-après "Valneva" ou "la Société") sont invités à [...]
Shire plc : Rule 2.9 Announcement
07/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 7 June 2018 Shire [...]
B-Temia and Wistron Join Forces to Launch Keeogo™ in Asia
07/06/2018
B-Temia and Wistron form B-Temia Asia to bring Keeogo™ to the Asian Market QUEBEC CITY, June 07, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., a Canadian biorobotics technology company and market leader in human mobility, [...]
Athersys Announces Expansion of Collaboration With Healios
07/06/2018
Healios receives rights to develop and commercialize additional indications and Athersys receives $20 million in license fees, plus potential milestones payments and royalties Discussions extended for China and other [...]
General Meeting to be held on June 28, 2018 and Availability of Related Materials
07/06/2018
LYON, France, June 07, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP) , a clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan [...]
Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S.
07/06/2018
Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S. Multiple scientific conference contributions at ASM Microbe highlight benefits of Unyvero LRT First commercial [...]
Madrigal Pharmaceuticals Prices Public Offering of Common Stock
07/06/2018
CONSHOHOCKEN, Pa., June 06, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic [...]
Optinose Announces Pricing of Public Offering of Common Stock
07/06/2018
YARDLEY, Pa., June 06, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $22.25 [...]
MPX Appoints Robert Petch to the Board of Directors
07/06/2018
TORONTO, June 06, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that Robert Petch has joined the board of directors of MPX. Mr. Petch has [...]
Arog Pharmaceuticals Announces Clinical Presentations on Crenolanib at the 23rd Congress of the European Hematology Association
07/06/2018
DALLAS, June 06, 2018 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet [...]
XORTX to Commence Trading on the OTCQB Venture Market
06/06/2018
CALGARY, Alberta, June 06, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism
06/06/2018
COPENHAGEN, Denmark, June 06, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]

Pages